Clinical Trials Sponsored by Celso Arango

Total 313 results

Celso Arango, MD, PhD
UMC Utrecht

Completed

Arbaclofen in Children and Adolescents With ASD (AIMS2-CT1)

Autism Spectrum Disorder

Spain, United Kingdom, France
Celso Arango
Comunidad de Madrid

Completed

Intervention Module AGES (AGES-CM)

Psychosis

Spain
Hospital Governador Celso Ramos

Completed

Use of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind Eye

Refractory Glaucoma | Blind Painful Eye | Control of Pain Through Drug Injection

Brazil
Cryobeauty
CEISO

Completed

Assessment of CRYOBEAUTY MAINS ET DECOLLETE Versus Liquid Nitrogen Cryotherapy, in the Treatment of Solar Lentigines (CBT-EC2)

Solar Lentigo

France
Cryonove Pharma
CEISO

Not yet recruiting

Performance and Tolerance of Cyto-selective Difluoroethane-based Cryotherapy in th Treatment of Brown Spots (Solar and Senile Lentigines, Post-Inflammatory Hyperpigmentation) on the Face and Hands of Asian Ethnicity Skins

Solar Lentigo | Senile Lentigo

France
Cryobeauty
CEISO

Completed

Clinical Evaluation of the Performance of a Difluoroethane-based Cyto-selective Cryotherapy to Treat Dark Spots on the Hand in 30 Volunteers. (CBT)

Solar Lentigo

France
Refill France
CEISO

Completed

Evaluation of the Dietary Supplement Refill Bypass to Reduce Nutritional Deficiencies of Patients Who Underwent Bariatric Surgery (Refill)

Obesity | Bariatric Surgery

France
Gelscom SAS
CEISO

Active, not recruiting

Ethanol Gel Versus Steroid in Refractory Lumbar Discogenic Pain (IDIS)

Lumbar Discogenic Pain (Disorder)

France
Celio Technology Inc.

Completed

A Study to Evaluate the Effect of Musashino Diabetes Diet in Type II Diabetes Mellitus Disease

Type II Diabetes Mellitus

Taiwan
SAV-IOL SA
CEISO

Recruiting

Evaluation of Efficacy and Long-term Safety for Lucidis Instant Focus© - PMCF Study Protocol

Cataract

Switzerland
Advanced Perfusion Diagnostics
CEISO

Completed

Tolerance and Safety of a Duodenal Probe Monitoring the Microcirculation (MC Monitor)

Multiple Organ Dysfunction Syndrome

France
Kevin Bruce

Not yet recruiting

Developing Protocols for Modelling of Genetic Diseases Using Induced Pluripotent Stem Cells

Genetic Disease
Cryonove Pharma
CEISO; Dermatech; INNOVSOLUTION

Completed

Tolerance and Mode of Administration of Cyto-selective Cryotherapy Treatments in Face Brown Spots: Proof of Concept (AGILE2)

Solar Lentigo

Ukraine
Vivaltis
CEISO; Human Physio

Not yet recruiting

Performance and Safety of the PHENIX LIBERTY, a Medical Device for Electrostimulation and Biofeedback, in the Treatment of Musculoskeletal Disorders

Musculoskeletal Disorder

France
Cryonove Pharma
CEISO; Dermatech

Completed

Tolerance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Post-inflamamatory Hyperpigmentation (PIH).

Post-inflammatory Hyperpigmentation

South Africa
Advanced Perfusion Diagnostics
CEISO

Completed

Monitoring Tissue Perfusion in Critically Ill or High-risk Surgical Patients (STEP UP)

High-risk Surgical Patients

France
SAV-IOL SA
CEISO

Completed

Evaluation of Efficacy and Long-term Safety for the InFo - Instant Focus © Lens / PMCF (INFOLO)

Cataract
Clinique Paris-Bercy
CEISO; ClinServ

Not yet recruiting

Prospective Evaluation of Subchondroplasty in Advanced Knee Osteoarthritis.

Knee Osteoarthritis

France
Cryonove Pharma
CEISO; Dermatech; INNOVSOLUTION

Completed

Tolerance of Cyto-selective Difluoroethane-based Cryotherapy (AGILE3)

Solar Lentigo

Ukraine
Cryonove Pharma
CEISO; Dermatech; INNOVSOLUTION

Completed

Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots PROOF OF CONCEPT (CRYO-EC4)

Lentigo Solar

Ukraine
Cryonove Pharma
CEISO; Dermatech; LTD HEALTH

Completed

Tolerance and Performance (Mode of Administration) of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots

Lentigo Solar | Senile Lentigo

Georgia
Cryonove Pharma
CEISO; Dermatech; LTD HEALTH

Completed

Tolerance and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots

Lentigo Solar

Georgia
Physio-Assist
University Hospital, Marseille; CEISO

Terminated

Evaluation of the Safety of the Medical Device Simeox® (SIMETOL)

Cystic Fibrosis | Chronic Bronchitis | Chronic Obstructive Airway Disease | Broncho-degenerative Disease | Idiopathic Bronchiectasis | Ciliary Dyskinesia

France
Aragon Pharmaceuticals, Inc.

Active, not recruiting

A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC (TITAN)

Prostate Cancer

United States, France, Poland, Ukraine, United Kingdom, China, Spain, Argentina, Israel, Mexico, Romania, Turkey, Korea, Republic of, Japan, Sweden, Canada, Russian Federation, Brazil, Germany, Hungary, Czechia, Australia
Aragon Pharmaceuticals, Inc.

Completed

Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone Acetate

Prostate Cancer

United States
Aragon Pharmaceuticals, Inc.

No longer available

An Expanded Access Protocol for Apalutamide Treatment of Participants With Non-Metastatic Castration-Resistant Prostate Cancer

Prostatic Neoplasms

Colombia, Brazil, Mexico
Aragon Pharmaceuticals, Inc.

Completed

A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc Study

Castration-Resistant Prostate Cancer

United States, Canada, Netherlands, United Kingdom, Moldova, Republic of
Aragon Pharmaceuticals, Inc.

Completed

The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer

Prostate Cancer

United States
Aragon Pharmaceuticals, Inc.

Completed

A Study to Assess the Relative Bioavailability of 7 Test Tablet Formulations of JNJ-56021927 With Respect to the Capsule Formulation of JNJ-56021927 in Healthy Male Participants

Healthy

United States
Aragon Pharmaceuticals, Inc.

Completed

Bioavailability Study of 3 Tablet Formulations vs. Capsule Formulation of JNJ-56021927 in Fasting Healthy Male Participants

Healthy

United States
Marengo Therapeutics, Inc.

Recruiting

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors (START-001)

Neoplasms | Urogenital Neoplasms | Neoplasms by Site | Carcinoma | Epstein-Barr Virus Infections | Advanced Solid Tumors | Vulvar Neoplasms | Vulvar Diseases | Abdominal Neoplasm | Lung Neoplasm | Papillomavirus Infection | Genital Neoplasm, Female

United States, Canada
Aragon Pharmaceuticals, Inc.

Active, not recruiting

An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)

Prostatic Neoplasms

United States, Australia, France, Germany, United Kingdom, Belgium, Spain, Argentina, South Africa, Japan, Canada, Netherlands, Korea, Republic of, Brazil, Russian Federation, Mexico
Aragon Pharmaceuticals, Inc.

Active, not recruiting

A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer (SPARTAN)

Prostatic Neoplasms

United States, Australia, France, Poland, United Kingdom, Germany, Taiwan, Spain, Belgium, Israel, Romania, Japan, Canada, Denmark, Finland, Korea, Republic of, Netherlands, New Zealand, Russian Federation, Hungary, Austria, Sweden, Slovaki... and more
Aragon Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Pharmacokinetics of JNJ-56021927 in Participants With Mild or Moderate Hepatic Impairment Compared With Participants With Normal Hepatic Function

Hepatic Impairment

United States
Aragon Pharmaceuticals, Inc.

Completed

14C-ARN-509 Microtracer Label AME and Absolute BA Study

Healthy

Netherlands
Aragon Pharmaceuticals, Inc.

Recruiting

A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer

Prostatic Neoplasms, Castration-Resistant

Moldova, Republic of, Spain
Aragon Pharmaceuticals, Inc.

Active, not recruiting

A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer

Prostatic Neoplasms | Metastatic Castration-Resistant Prostate Cancer

United States, Canada, Netherlands, United Kingdom
Aragon Pharmaceuticals, Inc.

Active, not recruiting

Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC)

Prostate Cancer

United States
Aragon Pharmaceuticals, Inc.

Active, not recruiting

An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS

Prostatic Neoplasms

United States, France, Poland, Taiwan, Ukraine, United Kingdom, China, Belgium, Germany, Spain, Israel, Mexico, Malaysia, Romania, Turkey, Canada, Netherlands, Korea, Republic of, Brazil, Russian Federation, Argentina, Sweden, Czechia
Aragon Pharmaceuticals, Inc.

Completed

Study to Assess Drug-Drug Interaction Between Itraconazole or Gemfibrozil and JNJ-56021927

Healthy

United States
Universidade Camilo Castelo Branco

Completed

Autonomic Testing in Subclinical Carotid Atherosclerosis (AtheroDetect)

Subclinical Carotid Atherosclerosis
Universidade Camilo Castelo Branco

Completed

Hiking Improves the Functional Autonomy

Aging

Brazil
Orange Park Medical Center

Unknown

WILD 5 Wellness: A 30-Day Intervention for Residents

Burnout, Professional | Mental Health Disorder | Mental Health Wellness 1 | Resident Wellness | Medical Residents | Resident Physician

United States
Universidade Camilo Castelo Branco

Unknown

Rehabilitation of Dynamic Muscle, Back Pain and Postural Balance (RDM)

Low Back Pain

Brazil
Universidade Camilo Castelo Branco

Completed

Effects of the Breathing Muscular Training of Institutionalized Elderly

In Brazil, Which Has an Increasing Number of Elderly People. | The Physiological Alterations of Aging Are Systemic.

Brazil
Tianjin Demax Medical Technology Co., Ltd
CEISO

Not yet recruiting

GUIDEX® Versus Launcher™ Guiding Catheter in Percutaneous Coronary Intervention (PCI) (GUIDEX_FR) (GUIDEX®_FR)

Coronary Artery Disease

France
Tango Therapeutics, Inc.

Recruiting

Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors

Cervical Cancer | Breast Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Endometrial Cancer | Solid Tumors, Adult | Carcinoma of Unknown Primary

United States
Tango Therapeutics, Inc.

Recruiting

Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors

Locally Advanced Solid Tumor

United States, France
Policlinico Abano Terme

Completed

Delayed Cord Clamping in Infants Born by 'Two-step' Vaginal Delivery

Placental Transfusion | Hematocrit Anemia

Italy
Policlinico Abano Terme

Unknown

Cord Milking in Elective Cesarean Section

Placental Transfusion

Italy

Clinical Trials Sponsored by Celso Arango

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations